Clonidine Tablets

Description

Clonidine Tablets (100mcg / 200mcg / 300mcg)

Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. is a specialized manufacturer of Clonidine Hydrochloride Tablets in India. Clonidine is a centrally acting alpha-2 adrenergic agonist used for hypertension and, in specific formulations or jurisdictions, other indications such as ADHD. Other uses may be off-label and require clinician assessment. As Clonidine is active at microgram doses, precise content uniformity is an important manufacturing requirement.

2. Product Specifications

3. Manufacturing Technology

• Content Uniformity: Validated geometric dilution and multi-stage blending support uniform distribution of the low-dose active ingredient.
• Score-Line Control: Where a presentation is registered as suitable for splitting, tablet hardness and score performance are controlled according to applicable specifications.
• Compression: Excipient and process selection are designed to minimize segregation and maintain consistent dosage units.
• Export Packaging: Packaging configurations are selected according to stability data and destination-market requirements.

4. Quality Assurance

• Dissolution: Finished tablets are tested against the applicable registered or pharmacopoeial dissolution specification.
• Assay & Dosage-Unit Uniformity: Potency and low-dose content uniformity are verified against approved specifications.
• Related Substances: Relevant impurities and degradation products are monitored during release and stability studies.

5. Clonidine Pharmacology and Uses

Clonidine stimulates central alpha-2 adrenergic receptors, reducing sympathetic outflow from the central nervous system. This can lower peripheral vascular resistance, heart rate and blood pressure.

• Hypertension: Used for blood-pressure management according to approved prescribing information.
• ADHD: Certain Clonidine formulations are approved for ADHD in some jurisdictions; immediate-release and extended-release products are not automatically interchangeable.
• Withdrawal Symptoms: Clonidine may be used under medical supervision to reduce selected autonomic symptoms during opioid withdrawal, but it does not treat opioid use disorder itself.
• Other Uses: Use for conditions such as tics or menopausal symptoms varies by jurisdiction and may be off-label.

6. Export and Regulatory Support

• Dossier Support: CTD and ACTD documentation where applicable.
• Certificates: FSC, COPP and COA where applicable.
• Logistics: Air or sea shipment via FOB Mumbai / CIF according to regulatory and commercial requirements.

7. Frequently Asked Questions

Q: Who manufactures Clonidine Tablets?
A: Healthy Life Pharma Pvt. Ltd. manufactures Clonidine tablet formulations in India.

Q: Is Clonidine sold under different brand names?
A: Yes. It is marketed under different brands internationally. Generic equivalence and interchangeability depend on the registered formulation and local regulatory requirements.

Q: Can Clonidine be stopped suddenly?
A: Abrupt discontinuation can cause rebound hypertension and sympathetic symptoms. Patients should follow a clinician-directed taper when discontinuation is required.

Q: Does Clonidine cause sleepiness?
A: Drowsiness and sedation are common. Patients should use caution with driving, alcohol and other sedating medicines.

Clinical Pharmacology & Safety Information

(For Registered Medical Practitioners & Patient Reference)

8. Dosage and Administration

• Dose: Initiation and titration depend on indication, formulation, blood pressure, heart rate, concomitant medicines and approved prescribing information.
• Microgram Strengths: Different markets use different strengths; prescriptions should be checked carefully to avoid microgram/milligram dosing errors.
• ADHD / Other Uses: Follow the formulation-specific registered label. Immediate-release and extended-release products can have different dosing instructions.
• Discontinuation: Do not stop abruptly; gradual dose reduction is generally required to reduce rebound hypertension risk.

9. Side Effects and Precautions

• Common Effects: Dry mouth, drowsiness, dizziness and constipation can occur.
• Cardiovascular: Hypotension and bradycardia can occur. Blood pressure and heart rate may require monitoring.
• Rebound Hypertension: Missed doses or abrupt withdrawal can cause a rapid rise in blood pressure, agitation, headache, tremor or other sympathetic symptoms.
• CNS Depressants: Alcohol, benzodiazepines, opioids and other sedating medicines can increase drowsiness and impairment.
• Beta-Blockers: Concomitant therapy and withdrawal sequencing require medical supervision because of heart-rate and rebound-hypertension considerations.

10. Storage Instructions

• Store below 25°C in a dry place.
• Keep the container tightly closed where supplied in bottles.
• Protect from excessive heat and moisture.
• Keep out of reach of children.